Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Carol Tevi-Benissan"'
Autor:
Carol Tevi-Benissan, Madeleine Okome, Maria Makuwa, Moise Ndong Nkoume, Joseph Lansoud-Soukate, Alain Georges, Marie-Claude Georges-Courbot, Laurent Belec
Publikováno v:
Emerging Infectious Diseases, Vol 4, Iss 1, Pp 130-131 (1998)
Externí odkaz:
https://doaj.org/article/5f840cf8e8e3422f91de6084be50d87d
Autor:
Molly Hancuh, Jenny Walldorf, Anna A. Minta, Carol Tevi-Benissan, Kira A. Christian, Yoann Nedelec, Kristen Heitzinger, Matthew Mikoleit, Amanda Tiffany, Adwoa D. Bentsi-Enchill, Lucy Breakwell
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:171-176
Autor:
Clement Lingani, Carol Tevi-Benissan, James M. Stuart, Marie-Pierre Preziosi, Olivier Ronveaux, Caroline Trotter, Katya Fernandez, Andre Bita, Laura V Cooper
Publikováno v:
The Lancet Infectious Diseases. 17:867-872
Summary Background In preparation for the introduction of MenAfriVac, a meningococcal group A conjugate vaccine developed for the African meningitis belt, an enhanced meningitis surveillance network was established. We analysed surveillance data on s
Autor:
Gaël Maufras du Châtellier, Halima Dao, Afework Assefa, Yusuf Nasir, Joseph Nsiari-Muzenyi Biey, Joseph Okeibunor, Bartholomew D. Akanmori, Blanche-Philomene Melanga Anya, Richard Mihigo, Dah Cheikh, Messeret Eshetu, Carol Tevi-Benissan
Publikováno v:
The Journal of Infectious Diseases
The Polio Eradication and Endgame Strategic plan outlines the phased removal of oral polio vaccines (OPVs), starting with type 2 poliovirus–containing vaccine and introduction of inactivated polio vaccine in routine immunization to mitigate against
Publikováno v:
The Pan African Medical Journal
The World Health Organization (WHO) African Region has approximately 100 million people with chronic hepatitis B virus (HBV) infection. This review describes the status of hepatitis B control in the Region. We present hepatitis B vaccine (HepB) cover
Autor:
Carol Tevi-Benissan, Shao Zhujun, Rabab Z. Jafri, Jon S. Abramson, David N Durrheim, Asad Ali, Juhani Eskola, Keith P. Klugman, Florence Fermon, Nancy E. Messonnier, Samba O. Sow, Zulfiqar A Bhutta, Mary Ramsay
Publikováno v:
Pathogens and Global Health. 108:11-20
A number of countries now include meningococcal vaccines in their routine immunization programs. This review focuses on different approaches to including meningococcal vaccines in country programs across the world and their effect on the burden of in
Autor:
Laure Dumolard, Pernille Jorgensen, Pushpa Ranjan Wijesinghe, James D. Heffelfinger, Joachim Hombach, Marc Perut, Justin R. Ortiz, Philipp Lambach, Carol Tevi-Benissan, M. Carolina Danovaro-Holliday, Alba Maria Ropero, Nadia Teleb
Publikováno v:
Vaccine
Introduction The WHO recommends annual influenza vaccination to prevent influenza illness in high-risk groups. Little is known about national influenza immunization policies globally. Material and Methods The 2014 WHO/UNICEF Joint Reporting Form (JRF
Autor:
Clement Lingani, Mamoudou Harouna Djingarey, Denis Kandolo, Ryan T. Novak, William Perea, Rodrigue Barry, Fabien Diomandé, Carol Tevi-Benissan, Florence Shirehwa, Marie-Pierre Preziosi, F. Marc LaForce
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. A group A meningococcal conjugate vaccine (PsA-TT) was developed specifically for the African “meningitis belt” and was prequalified by the World Health Organization (WHO) in June 2010. The vaccine was first used widely in Burkina Fas
Autor:
Kadidja Gamougam, Nehemie Mbakuliyemo, Denis Kandolo, Nancy E. Messonnier, James M. Stuart, F. Marc LaForce, Jean-Marc Collard, Paul A. Kristiansen, Ryan T. Novak, Doumagoum M. Daugla, William Perea, Brian Greenwood, Fabien Diomandé, Carol Tevi-Benissan, Mamoudou Harouna Djingarey, Marie-Pierre Preziosi, O. Walker, Thomas A. Clark, Dominique A. Caugant, Leonard W. Mayer
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2015, 61 (suppl_5), pp.S467-S472. ⟨10.1093/cid/civ499⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, Oxford University Press (OUP), 2015, 61 (suppl_5), pp.S467-S472. ⟨10.1093/cid/civ499⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
International audience; Background. During the first introduction of a group A meningococcal vaccine (PsA-TT) in 2010–2011 and its rollout from 2011 to 2013, >150 million eligible people, representing 12 hyperendemic meningitis countries, have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0f832aac82940364ba93875da5c003
https://researchonline.lshtm.ac.uk/id/eprint/2551457/1/civ499.PMC4639484.pdf
https://researchonline.lshtm.ac.uk/id/eprint/2551457/1/civ499.PMC4639484.pdf
Autor:
Paul I. Obiang, Minh Trinh Ngoc, Carol Tevi Benissan, David D. Bénoni, Jacques P. Amblard, André A. Renaut, Eric J. Bertherat, J. Lansoud-Soukate, Alain J. Georges, Marie Claude Georges-Courbot, Eric M. Leroy, Sylvain Baize, René J. Nabias, J. P.M. Lepage, E. Jean Wickings, J. M. Milleliri
Publikováno v:
The Journal of Infectious Diseases. 179:S65-S75
From the end of 1994 to the beginning of 1995, 49 patients with hemorrhagic symptoms were hospitalized in the Makokou General Hospital in northeastern Gabon. Yellow fever (YF) virus was first diagnosed in serum by use of polymerase chain reaction fol